Locate Wilmington, Delaware buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
Dr. Vishesh Agarwal, M.D.
501 West 14th Street
Department of Psychiatry
Wilmington, DE 19801
Main Tel: (302) 320-2962
|
Dr. Laurie Ann Spraga, D.O.
801 West Street
Wilmington, DE 19801
Main Tel: (302) 584-3984
|
Dr. Vishesh Agarwal, M.D.
501 West 14th Street
Department of Psychiatry 3N74
Wilmington, DE 19801
Main Tel: (302) 320-2962
|
Dr. Sowmya Kodali Kenia, M.D.
501 West 14th Street
Wilmington, DE 19801
Main Tel: (302) 320-2962
|
Dr. Charlene A. Browne, M.D.
31-32 A Trolley Square
Wilmington, DE 19806
Main Tel: (302) 777-5473
|
Dr. Norman R. Robinson, M.D.
31-A Trolley Square
Wilmington, DE 19806
Main Tel: (302) 777-5473
|
Dr. I. L. Lifrak, M.D.
1701 Augustine Cut off
Wilmington, DE 19803
Main Tel: (302) 654-7317
|
Andrew Donohue, M.D.
1701 Augustine Cut Off
Suite 8
Wilmington, DE 19803
Main Tel: (302) 235-3725
|
|
Dr. Elton John Smith,
1701 Augustine Cutoof
Suite 8
Wilmington, DE 19803
Main Tel: (302) 428-1701
|
Dr. Maria D. Perez, M.D.
1701 Augustine Cut-Off
Building 1, Suite 12
Wilmington, DE 19803
Main Tel: (302) 571-0730
|
Dr. Alina Gover, M.D.
1815 West 13th Street
Wilmington, DE 19806
Main Tel: (302) 652-4705
|
Dr. Jerome P. Gluckman, M.D.
1815 West 13th Street
Suite 1
Wilmington, DE 19806
Main Tel: (302) 655-2214
|
Dr. Albert Dworkin, M.D.
1815 West 13th Street
Suite 206
Wilmington, DE 19806
Main Tel: (302) 502-3869
|
Dr. Chandrakala Kathiravan, M.D.
Horizon House Inc.
1902a Maryland Avenue
Wilmington, DE 19805
Main Tel: (302) 655-7108
|
Dr. George Dutkewych, M.D.
Trolley Square
Suite 31- 32 A
Wilmington, DE 19806
Main Tel: (302) 777-5473
|
Carol Alvarado Barrentes,
2500 West 4th Street
Suite 6
Wilington, DE 19805
Main Tel: (302) 482-3388
|
Carol Alvarado Barrentes,
534 Greenhill Avenue
Wilmington, DE 19805
Main Tel: (302) 421-3388
|
Raphaele Todaro, M.D.
234 Philadelphia Pike
Suite 8
Wilmington, DE 19809
Main Tel: (302) 765-2345
|
|
Dr. Paul John Hannan, M.D.
2800 Lancaster Avenue
Suite 6
Wilmington, DE 19805
Main Tel: (623) 451-6398
|
Dr. Gregory Peter Papa, D.O.
3620 North Dupont Highway
New Castle, DE 19720
Main Tel: (302) 652-3545
|
Dr. Robyn Renee Miller, M.D.
1600 Rockland Road
Wilmington, DE 19803
Main Tel: (302) 651-6040
|
Dr. Krishna W. White, M.D.
Nemours/AIDHC
1600 Rockland Road
Wilmington, DE 19803
Main Tel: (302) 651-6207
|
Dr. Ranga N. Ram, M.D.
410 Foulk Road
Suite 105
Wilmington, DE 19803
Main Tel: (302) 762-2285
|
Raphaele Todaro, M.D.
701 Foulk Rd
Suite 2e
Wilmington, DE 19803
Main Tel: 302-765-2345
|
Dr. Adam Scott Bowman, M.D.
US Dept. of Veterans Affairs-Wilm. VAMC
1601 Kirkwood Highway
Wilmington, DE 19805
Main Tel: (302) 994-2511×2300
|
Dr. Somasunderam Padmalingam, M.D.
234 New Castle Avenue
New Castle, DE 19720
Main Tel: (302) 276-8602
|
Rinoo V. Shah, M.D.
Freedom Pain Centers, Inc.
390 North Broadway, Suite 300
Pennsville, NJ 08070
Main Tel: (856) 678-1111
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.